Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 23, 2017

Primary Completion Date

December 15, 2017

Study Completion Date

December 15, 2017

Conditions
Nocturia Due to Nocturnal Polyuria
Interventions
DRUG

SK-1404

4 weeks of repeated administration of SK-1404 to the patients of nocturia

DRUG

Placebo

4 weeks of repeated administration of Placebo to the patients of nocturia

Trial Locations (1)

Unknown

Investigational site (there may be other sites in this country), Tokyo

All Listed Sponsors
lead

Sanwa Kagaku Kenkyusho Co., Ltd.

INDUSTRY

NCT03116191 - Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects | Biotech Hunter | Biotech Hunter